Designing Smarter, More Precise Cancer Drugs: Q&A with Kevin Lou, PhD
A new study from researchers at UCSF and collaborating institutions, published in Nature, introduces a new framework for designing drugs that can bind to two sites on the same disease-causing protein, a discovery that ultimately could lead to more effective and safer therapies for patients.